Our Team has been active in building and investing in Longevity and Wellness focused businesses over the last Fourteen (14) years. As experienced investment bankers and health care innovators, we understand the trust you place in us when we recommend you place capital with us and our related companies.
To that end, we are currently assisting in raising capital for the following growth companies which we hold investment and leadership/management positions in:
The Charging Station, LLC
A new innovative Revenue Sharing investment company utilizing the most advanced light energy bed currently available in the market, the ARRC LED “Elysium” to support Light Bed Clinic revenues in major markets sponsored by the equipment manufacturer, ARRC LED. Clay Womack is the interim CFO, a Board Member and the initial investor into this entity.
Offering a $3,000,000 Convertible Secured Note, 3 year term at 8.5% paid quarterly. Note is convertible into 20% of the equity of the Company. Investors also get 35% off of MSRP of a Light Bed of their model choice as an additional reward for supporting the Company with a minimum investment of $100,000.
For access to Offering Documents, please CLICK HERE.
Sun Theory SPV IV
Sun Theory’s SPV IV (4th fund in series) represents a strategic expansion across the cannabis value chain with a commitment to delivering near-term cash flow, long-term growth, and attractive uncorrelated returns. Unlike traditional approaches, our portfolio strategy avoids cultivation, focusing instead on cash-flow-positive assets with significant growth potential. SPV IV offers you the chance to join an experienced team dedicated to delivering outsized returns through a combination of operational excellence and market insights.
Track record of investor bi-monthly cash returns across all Three (3) prior funds is very strong.
For access to the Corporate Deck, please CLICK HERE.
Pressure Partners, Inc.
A new startup by our experienced hyperbaric clinic management team (Clay Womack and Joshua Womack) to build out the first national chain of hyperbaric oxygen therapy and “chamber showroom” centers focused on the hundreds of “Off-Label” uses for this therapeutic modality in the Longevity and Wellness industries. In addition, we will be financing other clinics acquisition of Hyperbaric equipment from us on a Revenue Sharing basis. Our focus mission is operations training and financing clinics primarily started and owned by Veterans that will also make these treatment centers available for treating our Veterans along with the general public.
For access to the Corporate Deck, please CLICK HERE.
Direct Biologics, Inc.
DBI is a developmental stage pharmaceutical company with an ARDS drug currently enrolling patients in Phase 3 clinical trials. This drug will be the first 100% biologic drug (no chemicals) ever approved by the FDA. There is no drug currently in the market to treat ARDS, an $18 billion addressable market. The Company has a significant manufacturing IP portfolio to go with its industry leading biologic drug lineup. Dr. Eleanor Womack has been on this company’s Scientific Advisory Board for over Seven years, Clay Womack has been on the Capital Advisory Board for Two years.
For access to the Corporate Deck, please CLICK HERE.
Sales
To Place an Order or ask questions
Join us. It will only take a minute
Get In Touch
We'd love to hear from you